Meprobam en es it fr

Meprobam Brand names, Meprobam Analogs

Meprobam Brand Names Mixture

  • No information avaliable

Meprobam Chemical_Formula


Meprobam RX_link

Meprobam fda sheet

Meprobam msds (material safety sheet)

Meprobam Synthesis Reference

Berger, Ludwig, U.S. Pat. 2,937,119 (1960)

Meprobam Molecular Weight

260.33 g/mol

Meprobam Melting Point

92-93 oC

Meprobam H2O Solubility

0.3 mg/ml

Meprobam State


Meprobam LogP


Meprobam Dosage Forms


Meprobam Indication

For the relief of discomfort associated with acute, painful, musculoskeletal conditions.

Meprobam Pharmacology

Carisoprodol is used as a skeletal muscle relaxant. One of its metabolites, meprobamate, is available as an anxiolytic agent.

Meprobam Absorption

No information avaliable

Meprobam side effects and Toxicity

Symptoms of overdose include drowsiness, giddiness, nausea, indigestion, or rash. Other adverse effects attributed to therapeutic use of carisoprodol include dizziness, irritability, insomnia, diplopia, temporary loss of vision, ataxia, weakness, headache, and dysarthria. Non-CNS adverse effects include gastrointestinal complaints, tachycardia, and postural hypotension. Patients sensitive to sulfites or tartrazine may experience wheezing, allergic rashes including erythema multiforme, or anaphylaxis after using some preparations of carisoprodol which contain such additives

Meprobam Patient Information

Carisoprodol is a muscle relaxant used to relieve the pain and stiffness of muscle spasms and discomfort due to strain and sprain. Inform your physician if you are pregnant or nursing. Do not take this medication with a monoamine oxidase inhibitor. This medication may cause dizziness, drowsiness, or blurred vision; use caution while driving or operating hazardous machinery. Do not take any other sedating drugs or drink alcohol while taking carisoprodol. If dizziness occurs, avoid sudden changes in posture. Take this medication with food to avoid stomach upset. Notify your physician if you develop trouble breathing, unexplained fever, severe weakness, vision changes, swelling, or skin rash. Withdrawal symptoms may occur if therapy is suddenly stopped in a patient on long-term or high-dose therapy.

Meprobam Organisms Affected

Humans and other mammals